Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lestaurtinib in Infants With MLL-rearranged ALL (AALL0631)
NCT00557193Phase 3Completed
- Sponsor
- Children's Oncology Group
- Start
- Jan 2008
- Primary completion
- Sep 2017
- Countries
- 4
01
Overview
A Phase 3 trial of lestaurtinib in acute lymphoblastic leukemia (ALL), acute undifferentiated leukemia (AUL), sponsored by Children's Oncology Group. Started Jan 2008; status: completed.
02
Drugs
lestaurtinib
03
Conditions
acute lymphoblastic leukemia (ALL)acute undifferentiated leukemia (AUL)
Beyond the preview
Go deeper on NCT00557193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00557193.